Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Jul 2021
Historique:
received: 25 05 2021
revised: 30 06 2021
accepted: 06 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 18 8 2021
Statut: epublish

Résumé

Pathological fibrosis of the liver is a landmark feature in chronic liver diseases, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Diagnosis and assessment of progress or treatment efficacy today requires biopsy of the liver, which is a challenge in, e.g., longitudinal interventional studies. Molecular imaging techniques such as positron emission tomography (PET) have the potential to enable minimally invasive assessment of liver fibrosis. This review will summarize and discuss the current status of the development of innovative imaging markers for processes relevant for fibrogenesis in liver, e.g., certain immune cells, activated fibroblasts, and collagen depositions.

Identifiants

pubmed: 34298967
pii: ijms22147348
doi: 10.3390/ijms22147348
pmc: PMC8306605
pii:
doi:

Substances chimiques

Alarmins 0
Aquaporins 0
CCR2 protein, human 0
Ccr2 protein, mouse 0
Contrast Media 0
Cytokines 0
Fatty Acids 0
Fluorine Radioisotopes 0
Gallium Radioisotopes 0
Membrane Proteins 0
Radiopharmaceuticals 0
Receptors, CCR2 0
Triglycerides 0
Collagen 9007-34-5
Gallium-68 98B30EPP5S
Endopeptidases EC 3.4.-
fibroblast activation protein alpha EC 3.4.21.-
Fluorine-18 GZ5I74KB8G

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : EFSD/Lilly
ID : no applicable
Organisme : Magnus Bergvalls Foundation
ID : no applicable
Organisme : the Swedish Research Council
ID : no applicable
Organisme : Science for Life Laboratory
ID : no applicable

Références

Sci Rep. 2019 Oct 18;9(1):14960
pubmed: 31628379
Mol Imaging Biol. 2020 Feb;22(1):105-114
pubmed: 31065895
Clin Sci (Lond). 2018 Apr 16;132(7):813-824
pubmed: 29440620
Inflamm Regen. 2016 Oct 18;36:19
pubmed: 29259692
Trends Mol Med. 2018 May;24(5):458-471
pubmed: 29665983
Gastroenterology. 2016 Mar;150(3):626-637.e7
pubmed: 26677985
Cells. 2019 Nov 11;8(11):
pubmed: 31718044
Cell Mol Immunol. 2021 Jan;18(1):38-44
pubmed: 33159158
Clin Sci (Lond). 2014 Nov;127(10):603-13
pubmed: 24814875
Lancet Gastroenterol Hepatol. 2016 Sep;1(1):56-67
pubmed: 28404113
EJNMMI Res. 2020 Oct 31;10(1):133
pubmed: 33128636
Expert Opin Investig Drugs. 2020 Feb;29(2):103-106
pubmed: 31615278
J Nucl Med. 2014 Feb;55(2):294-300
pubmed: 24408895
MAbs. 2010 Mar-Apr;2(2):137-47
pubmed: 20190560
J Nucl Med. 2019 Jun;60(6):858-863
pubmed: 30413657
Cells. 2020 Apr 03;9(4):
pubmed: 32260126
J Clin Invest. 2019 Jan 2;129(1):24-33
pubmed: 30601139
J Transl Med. 2017 Apr 11;15(1):75
pubmed: 28399886
Cells. 2020 Apr 10;9(4):
pubmed: 32290100
Amino Acids. 2017 Jan;49(1):89-101
pubmed: 27633720
Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11966-11971
pubmed: 31123149
Nat Rev Gastroenterol Hepatol. 2018 Jun;15(6):349-364
pubmed: 29740166
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20
pubmed: 28930295
J Chin Med Assoc. 2021 Mar 1;84(3):261-266
pubmed: 33306598
Hepatol Commun. 2020 Jan 14;4(4):478-492
pubmed: 32258944
Diabetologia. 2016 Jul;59(7):1340-1349
pubmed: 27094935
Am J Transl Res. 2020 May 15;12(5):1491-1514
pubmed: 32509158
Nucl Med Biol. 2014 Oct;41(9):728-36
pubmed: 25023066
Diabetes. 2018 Dec;67(12):2485-2493
pubmed: 30459251
Am J Respir Crit Care Med. 2019 Jul 15;200(2):258-261
pubmed: 31161770
J Anim Physiol Anim Nutr (Berl). 2008 Jun;92(3):272-83
pubmed: 18477307
Nat Immunol. 2018 Mar;19(3):222-232
pubmed: 29379119
Angew Chem Int Ed Engl. 2015 Sep 7;54(37):10980-4
pubmed: 26216251
J Nucl Med. 2021 Jun 1;62(6):833-838
pubmed: 33097629
Front Physiol. 2018 Jul 10;9:851
pubmed: 30042691
Nucl Med Biol. 2021 Feb;93:54-62
pubmed: 33321470
Hepatology. 2021 May;73(5):2028-2038
pubmed: 33111374
Hepatol Commun. 2018 Dec 27;3(2):246-261
pubmed: 30766962
J Hepatol. 2020 Jul;73(1):202-209
pubmed: 32278004
Adv Sci (Weinh). 2020 Nov 09;7(24):2002997
pubmed: 33344141
Angew Chem Int Ed Engl. 2007;46(43):8171-3
pubmed: 17893943
J Pediatr Gastroenterol Nutr. 2014 Dec;59(6):679-83
pubmed: 25079481
J Hepatol. 2020 Jul;73(1):210-211
pubmed: 32402525
Cancer Res. 2018 Oct 1;78(19):5706-5717
pubmed: 30115693
Immunity. 2013 Aug 22;39(2):357-71
pubmed: 23954132
Nat Metab. 2019 Jun;1(6):604-614
pubmed: 31701087
J Hepatol. 2020 Jul;73(1):161-169
pubmed: 32145257
Expert Rev Gastroenterol Hepatol. 2021 Jan;15(1):51-64
pubmed: 32878486
Radiology. 2017 Jun;283(3):758-768
pubmed: 28045644
Curr Pathobiol Rep. 2015 Dec;3(4):253-261
pubmed: 26726307
Diabetol Metab Syndr. 2020 Jul 14;12:60
pubmed: 32684985
Front Biosci (Landmark Ed). 2019 Jan 1;24(1):1-17
pubmed: 30468644
PLoS One. 2009;4(5):e5585
pubmed: 19440310
PLoS One. 2018 May 17;13(5):e0197213
pubmed: 29771932
J Hepatol. 2013 Nov;59(5):992-8
pubmed: 23838178
J Nucl Med. 2020 Sep;61(9):1355-1360
pubmed: 32111688
Nat Rev Gastroenterol Hepatol. 2018 Aug;15(8):461-478
pubmed: 29844588
Sci Transl Med. 2017 Apr 5;9(384):
pubmed: 28381537
Cell Mol Immunol. 2014 May;11(3):224-31
pubmed: 24633014
Nat Commun. 2019 Oct 29;10(1):4777
pubmed: 31664017
EJNMMI Res. 2015 Dec;5(1):71
pubmed: 26650603
Radiology. 2017 Aug;284(2):390-400
pubmed: 28358240
Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2836-2845
pubmed: 32447444
Stem Cells Int. 2019 Apr 4;2019:6795845
pubmed: 31089331
Gastroenterology. 2017 Feb;152(3):598-607.e2
pubmed: 27911262
Medicines (Basel). 2018 May 28;5(2):
pubmed: 29843404
Ann Nucl Med. 2019 Nov;33(11):806-812
pubmed: 31388833
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
J Clin Invest. 2017 Jan 3;127(1):55-64
pubmed: 28045404
Am J Physiol Gastrointest Liver Physiol. 2011 Sep;301(3):G425-34
pubmed: 21659620
Sci Rep. 2015 Nov 27;5:17327
pubmed: 26612465

Auteurs

Olivia Wegrzyniak (O)

Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, SE-751 83 Uppsala, Sweden.

Maria Rosestedt (M)

Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, SE-751 83 Uppsala, Sweden.

Olof Eriksson (O)

Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, SE-751 83 Uppsala, Sweden.
Antaros Medical AB, SE-431 83 Mölndal, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH